New study tailors surgery and radiation to each Patient's response in advanced breast cancer
NCT ID NCT07376538
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for women with advanced breast cancer that has spread to nearby lymph nodes. After initial chemotherapy, doctors will adjust the next steps—surgery and radiation—based on how much cancer remains. The goal is to see if this personalized approach can help people live longer without the cancer coming back. About 157 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
response-adapted radiation and surgery
What this could lead to
If successful, this could lead to more personalized, effective treatment for advanced breast cancer, potentially improving survival and reducing unnecessary procedures.
What could go wrong
This is a phase 2 trial with only 157 participants, so results may not apply to everyone. The approach is complex and may not improve outcomes or could cause side effects from intensified therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••